Depression with an estimated prevalence of 35% is a frequent manifestation of dementia
with Lewy bodies (DLB), having negative effects on cognitive performance and life …

Background: Alzheimer's disease is the most common neurodegenerative disorder in our
society, mainly characterized by loss of cognitive function. However, other symptoms such …

Introduction: Cannabigerol (CBG), and its precursor before decarboxylation, cannabigerolic
acid is sometimes labeled the “mother of all cannabinoids.” The purpose of the present study …

Growing evidence suggests that neuroinflammation plays a critical role in the pathogenesis
of neurodegenerative diseases. Peripheral markers of inflammation, including blood cell …

The objective of this study was to characterize the epidemiology of using potentially
inappropriate medications associated with dementia exacerbation (DPIMs) in elderly …

Objective Examine the association between the co-prescribing of opioids, benzodiazepines,
gabapentinoids (pregabalin and gabapentin) and selective serotonin reuptake …

With the improvement of living standards, dietary interventions have become an appropriate
approach to enhance memory and cognitive performance. The present study investigated …

Objectives: The aim of this systematic review is to examine the cognitive impact of
psychotropic medications including benzodiazepines, antidepressants, mood stabilizers …

Background In dementia, a number of factors may influence functional decline in addition to
cognition. In this study, we aimed to study the potential association of the number of …

Background There is limited knowledge regarding the process of deprescribing psychotropic
drugs to people with dementia (PwD) conducted by general practitioners (GP). We …